Terms: = Leukemia AND BTG1, P62324, 694, ENSG00000133639
120 results:
1. Epidemiological characteristics and influencing factors of acute leukemia in children and adolescents and adults: a large population-based study.
Liu S; Hu B; Zhang J
Hematology; 2024 Dec; 29(1):2327916. PubMed ID: 38578123
[TBL] [Abstract] [Full Text] [Related]
2. The predictive value of btg1 for the response of newly diagnosed acute myeloid leukemia to decitabine.
Li Y; Mao X; Li M; Li L; Tong X; Huang L
Clin Epigenetics; 2024 Jan; 16(1):16. PubMed ID: 38254153
[TBL] [Abstract] [Full Text] [Related]
3. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
[TBL] [Abstract] [Full Text] [Related]
4. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
5. Single-cell combined with bulk-RNA data reveal a pattern related to angiogenesis in breast cancer patients: Individualized medicine.
Zhang W; Yu Y; Yang F
Environ Toxicol; 2024 Feb; 39(2):695-707. PubMed ID: 37647361
[TBL] [Abstract] [Full Text] [Related]
6. The predictive utility of cytokines, procalcitonin and C-reactive protein among febrile pediatric hematology and oncology patients with severe sepsis or septic shock.
Lin SP; Xu XJ; Liao C; Zhao N; Chen YY; Song H; Xu WQ; Liang J; Shen DY; Zhang JY; Shen HP; Zhao FY; Tang YM
Pediatr Hematol Oncol; 2024; 41(1):1-14. PubMed ID: 37452625
[TBL] [Abstract] [Full Text] [Related]
7. Vincristine and dexamethasone pulses in addition to maintenance therapy among pediatric acute lymphoblastic leukemia (GD-ALL-2008): An open-label, multicentre, randomized, phase III clinical trial.
Qiu KY; Wang JY; Huang LB; Li CG; Xu LH; Liu RY; Chen HQ; Ruan YS; Zhen ZJ; Li CK; Fang JP
Am J Hematol; 2023 Jun; 98(6):869-880. PubMed ID: 36877527
[TBL] [Abstract] [Full Text] [Related]
8. Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL.
Aldoss I; Khaled SK; Wang X; Palmer J; Wang Y; Wagner JR; Clark MC; Simpson J; Paul J; Vyas V; Chien SH; Stein A; Pullarkat V; Salhotra A; Al Malki MM; Aribi A; Sandhu K; Thomas SH; Budde LE; Marcucci G; Brown CE; Forman SJ
Clin Cancer Res; 2023 Feb; 29(4):742-753. PubMed ID: 36255386
[TBL] [Abstract] [Full Text] [Related]
9. Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton-Pump Inhibitors.
Sharma S; Pepin X; Burri H; Zheng L; Kuptsova-Clarkson N; de Jong A; Yu T; MacArthur HL; Majewski M; Byrd JC; Furman RR; Ware JA; Mann J; Ramies D; Munugalavadla V; Sheridan L; Tomkinson H
Clin Pharmacol Drug Dev; 2022 Nov; 11(11):1294-1307. PubMed ID: 36029150
[TBL] [Abstract] [Full Text] [Related]
10. Emerging role of anti-proliferative protein btg1 and BTG2.
Kim SH; Jung IR; Hwang SS
BMB Rep; 2022 Aug; 55(8):380-388. PubMed ID: 35880434
[TBL] [Abstract] [Full Text] [Related]
11. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends.
Huang J; Chan SC; Lok V; Zhang L; Lucero-Prisno DE; Xu W; Zheng ZJ; Elcarte E; Withers M; Wong MCS;
Lancet Haematol; 2022 Sep; 9(9):e670-e677. PubMed ID: 35843248
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical Study on Dynamic Detection of Minimal Residual Disease in Acute Myeloid leukemia by Multiparameter Flow Cytometry].
Jin Y; Wang AY; Wang XB; Yang HZ; Liu X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):737-743. PubMed ID: 35680798
[TBL] [Abstract] [Full Text] [Related]
13. Indications for cryopreservation and autotransplantation of ovarian tissue.
Gjeterud J; Kristensen SG; Fedder J
Tidsskr Nor Laegeforen; 2021 Oct; 141(2021-15):. PubMed ID: 34726041
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.
Moorman AV; Barretta E; Butler ER; Ward EJ; Twentyman K; Kirkwood AA; Enshaei A; Schwab C; Creasey T; Leongamornlert D; Papaemmanuil E; Patrick P; Clifton-Hadley L; Patel B; Menne T; McMillan AK; Harrison CJ; Rowntree CJ; Marks DI; Fielding AK
Leukemia; 2022 Mar; 36(3):625-636. PubMed ID: 34657128
[TBL] [Abstract] [Full Text] [Related]
15. Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018.
Ortega-Ortega M; Hanly P; Pearce A; Soerjomataram I; Sharp L
Int J Cancer; 2022 Feb; 150(4):580-593. PubMed ID: 34569617
[TBL] [Abstract] [Full Text] [Related]
16. Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition.
Lew TE; Lin VS; Cliff ER; Blombery P; Thompson ER; Handunnetti SM; Westerman DA; Kuss BJ; Tam CS; Huang DCS; Seymour JF; Roberts AW; Anderson MA
Blood Adv; 2021 Oct; 5(20):4054-4058. PubMed ID: 34478505
[TBL] [Abstract] [Full Text] [Related]
17. Proposal and clinical application of molecular genetic risk scoring system, "MRplus", for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre.
Gupta SK; Bakhshi S; Kamal VK; Gupta R; Sharma P; Pushpam D; Sahoo RK; Sharma A
Leuk Res; 2021 Dec; 111():106683. PubMed ID: 34371436
[TBL] [Abstract] [Full Text] [Related]
18. [The Auxiliary Diagnostic Value of Serum Adenosine Deaminase in Acute leukemia at Clinical Test].
Liu P; Yang CM; Ye N; Dong SL; Li M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1119-1122. PubMed ID: 34362490
[TBL] [Abstract] [Full Text] [Related]
19. [Clinical and prognostic values of TP53 mutation in patients with B-lineage acute lymphoblastic leukemia].
Du YY; Lyu KK; Xu MM; Yao WQ; Kang HZ; Han Y; Tang XW; Ma X; Wu XJ; He XF; Wu DP; Liu YJ
Zhonghua Xue Ye Xue Za Zhi; 2021 May; 42(5):396-401. PubMed ID: 34218582
[No Abstract] [Full Text] [Related]
20. Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials.
Eckert C; Parker C; Moorman AV; Irving JA; Kirschner-Schwabe R; Groeneveld-Krentz S; Révész T; Hoogerbrugge P; Hancock J; Sutton R; Henze G; Chen-Santel C; Attarbaschi A; Bourquin JP; Sramkova L; Zimmermann M; Krishnan S; von Stackelberg A; Saha V
Eur J Cancer; 2021 Jul; 151():175-189. PubMed ID: 34010787
[TBL] [Abstract] [Full Text] [Related]
[Next]